FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40445011000001101: Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Feb 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1941201000001115 Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1941221000001110 Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Is a Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has AMP Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has excipient Lactose false Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start